CBIO Crescent Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$14.32
· of 52w range
· above low
· to high
$8.7252w low
$27.4152w high
Market Cap (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Revenue
$11M
your badges
52W Range
$9–$27
Analyst Rating
BUY
Price Target
$31
P/E
-29.2
ROE
-90.0%
Net Profit Margin
-1419.6%
Your badge strip is empty — pin a metric anywhere on this page.
CBIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$14.32
Market Cap (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Revenue
$11M
ROE
-90.0%
52W Range
$9–$27
CBIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 16, 2025 | 1-for-100 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$11M2016-12-31 → 2025-12-31
EPS$-0.592019-12-31 → 2024-12-31
Free Cash Flow$-72M2016-12-31 → 2025-12-31
Net margin-1419.6%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CBIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -29.25Y avg ≈-186.2 | ≈-186.2 | · | · | |
| P/S | 36.45Y avg ≈436476.1 | ≈436476.1 | 144.0 | Undervalued | |
| P/B (MRQ) | 2.45Y avg ≈235.3 | ≈235.3 | 3.0 | Fair value | |
| Price / FCF (TTM) | -5.45Y avg ≈-195.4 | ≈-195.4 | · | · | |
| Price / Cash Flow (TTM) | -5.55Y avg ≈-195.6 | ≈-195.6 | · | · | |
| Price / Tangible Book | 1.95Y avg ≈218.3 | ≈218.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CBIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -1407.5%5Y avg ≈-115708.9% | ≈-115708.9% | -2380.1% | In line | |
| EBITDA Margin | -1407.5%5Y avg ≈-115708.9% | ≈-115708.9% | -2380.1% | In line | |
| Pretax Margin | -1401.2% | · | -5050.3% | Top tier | |
| Net Profit Margin | -1419.6%5Y avg ≈-109533.6% | ≈-109533.6% | -2240.9% | In line | |
| ROA | -111.6%5Y avg ≈-87.8% | ≈-87.8% | -40.8% | Weak | |
| ROE | -90.0%5Y avg ≈-447.8% | ≈-447.8% | -52.8% | Weak | |
| ROIC | -76.2% | · | -39.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CBIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 9.75Y avg ≈5.7 | ≈5.7 | 12.9 | Low liquidity | |
| Quick Ratio | 6.45Y avg ≈5.5 | ≈5.5 | 10.5 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CBIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -86.7%5Y avg ≈-89.6% | ≈-89.6% | · | · | |
| Revenue CAGR 3Y | 424.9% | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CBIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.0 | ≈0.0 | 0.0 | Top tier | |
| Receivables Turnover | 1.2 | · | · | · | |
| Revenue / Employee | ≈$157.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$96.00
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jan 13, 2023 | $24.00 | USD | ≈55.3% |
| Sep 21, 2022 | $143.00 | USD | ≈223.4% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.05%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.74 | $-0.81 | 8.7% | |
| March 31, 2026 | $-0.70 | $-0.97 | 27.5% | |
| Dec. 31, 2025 | $-0.54 | $-2.57 | 79.0% | |
| Sept. 30, 2025 | $-1.27 | $-2.02 | 37.2% | |
| June 30, 2025 | $-4.93 | $-1.80 | -174.2% | |
| March 31, 2025 | $-4.00 | $-5.10 | 21.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.37 | $0.08 | $0.60 | $0.79 | $1.56 | $2.62 | $3.55 | $4.76 | $3.48 | $1.52 | $2.12 | $2.68 | |
| Revenue / Share | · | · | $0.00 | $0.00 | $0.02 | · | · | · | · | · | · | $0.81 | |
| Cash Flow / Share | · | $-0.48 | $-0.55 | $-0.88 | $-1.12 | · | · | · | · | · | · | $-0.23 | |
| Cash / Share | $7.74 | $0.17 | $0.65 | $0.88 | $1.73 | $2.80 | $3.64 | $4.86 | $3.61 | $1.72 | $2.46 | $2.91 | |
| EPS (TTM) | $-0.49 | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-0.75 | $-0.75 | $-0.75 | $-0.71 | $-0.60 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | · | 64,483,958 | 64,483,848 | 64,457,233 | · | 64,349,709 | 64,276,184 | 60,350,127 | · | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 64,483,958 | 64,483,848 | 64,522,257 | · | 64,349,709 | 64,276,184 | 64,457,233 | · | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | · | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | · | · | · | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | · | · | · | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | · | · | · | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | · | · | · | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | · | · | $8.40 | $10.02 | · | · | · | $0.31 | $0.45 | · | $0.72 | $0.85 | $0.97 | · | $0.92 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.16 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $6.18 | · | · | $9.59 | $10.99 | · | · | · | $0.35 | $0.49 | · | $0.77 | $0.90 | $1.01 | · | $0.98 | |
| EPS (TTM) | $-0.59 | $-0.49 | · | $-0.59 | $-0.59 | $-0.59 | · | $-0.49 | $-0.48 | $-0.45 | · | $-0.64 | $-0.66 | $-0.78 | · | $-1.02 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-69M | $-54M | $-42M | · | $-40M | $-39M | $-37M | · | $-38M | $-37M | $-42M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | · | · | · | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -30.5 | -37.5 | · | -20.2 | -27.4 | -35.6 | · | -34.7 | -58.3 | -666.7 | · | -234.4 | -263.6 | -161.5 | · | -53.9 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | · | · | · | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| Earnings Yield | -3.3% | -2.7% | · | -5.0% | -3.7% | -2.8% | · | -2.9% | -1.7% | -0.15% | · | -0.43% | -0.38% | -0.62% | · | -1.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M |
| Operating Margin % | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M |
| Diluted EPS | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M |
Institutional owners (13F) 82 filers · $526.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
82
Value held
$526.1M
New positions
32
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 32 (+15 vs prior Q) | 12 (+2 vs prior Q) | 17 (0 vs prior Q) | 14 (+6 vs prior Q) | +4.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $74,403,252 | 4,133,514 | 14.14% | Shares |
| BVF INC/IL | $49,477,734 | 2,748,763 | 9.40% | Shares |
| Fairmount Funds Management LLC | $49,461,588 | 2,747,866 | 9.40% | Shares |
| Venrock Adviser, LLC | $38,404,368 | 2,133,576 | 7.30% | Shares |
| Logos Global Management LP | $34,200,000 | 1,900,000 | 6.50% | Shares |
| FCPM III SERVICES B.V. | $30,201,336 | 1,677,852 | 5.74% | Shares |
| Balyasny Asset Management L.P. | $29,932,506 | 1,662,917 | 5.69% | Shares |
| Vestal Point Capital, LP | $29,340,000 | 1,630,000 | 5.58% | Shares |
| Opaleye Management Inc. | $23,748,318 | 1,319,351 | 4.51% | Shares |
| BlackRock, Inc. | $22,891,716 | 1,271,762 | 4.35% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $20,880,000 | 1,160,000 | 3.97% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $13,819,590 | 767,755 | 2.63% | Shares |
| MILLENNIUM MANAGEMENT LLC | $7,269,462 | 403,859 | 1.38% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $6,923,843 | 384,576 | 1.32% | Shares |
| JENNISON ASSOCIATES LLC | $6,813,126 | 378,507 | 1.30% | Shares |
| RTW INVESTMENTS, LP | $6,711,408 | 372,856 | 1.28% | Shares |
| NEXTBio Capital Management LP | $6,711,408 | 372,856 | 1.28% | Shares |
| VANGUARD GROUP INC | $6,612,021 | 557,506 | 1.26% | Shares |
| Remedium Capital Partners, LLC | $6,502,500 | 361,250 | 1.24% | Shares |
| STATE STREET CORP | $5,680,566 | 315,587 | 1.08% | Shares |
| AMERIPRISE FINANCIAL INC | $5,446,224 | 302,568 | 1.04% | Shares |
| Point72 Asset Management, L.P. | $5,400,000 | 300,000 | 1.03% | Shares |
| MARSHALL WACE, LLP | $3,857,400 | 214,300 | 0.73% | Shares |
| PERCEPTIVE ADVISORS LLC | $3,724,956 | 206,942 | 0.71% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,398,454 | 188,803 | 0.65% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,363,732 | 186,874 | 0.64% | Shares |
| STEMPOINT CAPITAL LP | $3,282,876 | 182,382 | 0.62% | Shares |
| UBS Group AG | $3,153,276 | 175,182 | 0.60% | Shares |
| NORTHERN TRUST CORP | $2,498,004 | 138,778 | 0.47% | Shares |
| Exome Asset Management LLC | $2,299,842 | 127,769 | 0.44% | Shares |
| SECTORAL ASSET MANAGEMENT INC | $2,183,400 | 121,300 | 0.42% | Shares |
| Woodline Partners LP | $1,700,784 | 94,488 | 0.32% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,354,050 | 75,225 | 0.26% | Shares |
| Burkehill Global Management, LP | $1,332,000 | 74,000 | 0.25% | Shares |
| Blackstone Inc. | $1,127,646 | 62,647 | 0.21% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1,063,872 | 59,104 | 0.20% | Shares |
| Y-Intercept (Hong Kong) Ltd | $914,832 | 50,824 | 0.17% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904,644 | 50,258 | 0.17% | Shares |
| Nuveen, LLC | $857,322 | 47,629 | 0.16% | Shares |
| Bank of New York Mellon Corp | $824,004 | 45,778 | 0.16% | Shares |
| Stonepine Capital Management, LLC | $720,000 | 40,000 | 0.14% | Shares |
| BANK OF AMERICA CORP /DE/ | $464,778 | 25,821 | 0.09% | Shares |
| RHUMBLINE ADVISERS | $458,766 | 25,487 | 0.09% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $450,000 | 25,000 | 0.09% | Shares |
| Squarepoint Ops LLC | $434,988 | 24,166 | 0.08% | Shares |
| AMERICAN CENTURY COMPANIES INC | $410,490 | 22,805 | 0.08% | Shares |
| TWO SIGMA ADVISERS, LP | $385,450 | 32,500 | 0.07% | Shares |
| WELLS FARGO & COMPANY/MN | $354,600 | 19,700 | 0.07% | Shares |
| ADAR1 Capital Management, LLC | $328,950 | 18,275 | 0.06% | Shares |
| Virtus Investment Advisers, LLC | $328,644 | 18,258 | 0.06% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 filings | July 20, 2026 | 16.52% | Amendment | Passive investment | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 filings | June 20, 2025 | 0.37% | Amendment | · | SEC |
| May 8, 2024 | · | Initial filing | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 filings | Feb. 29, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 34 insiders · 16 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | Sept. 18, 2026 S | 271,765 | 0 | 3 | $-920,842 |
| Harout Semerjian | Chief Executive Officer | Jan. 12, 2024 A | 25,000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | Sept. 16, 2026 S | 19,730 | 0 | 2 | $-30,172 |
| Brian M. Hahn | SVP Finance, CFO | June 18, 2024 P | 70,643 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | Sept. 18, 2026 S | 134,588 | 0 | 3 | $-446,912 |
| Jan Pinkas | Chief Scientific Officer | Sept. 16, 2026 S | 21,581 | 0 | 2 | $-34,949 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | Sept. 16, 2026 S | 18,710 | 0 | 2 | $-33,010 |
| Ellie Eunkyung Im | Chief Medical Officer | Sept. 16, 2026 S | 21,446 | 0 | 2 | $-33,082 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | Sept. 16, 2026 S | 13,631 | 0 | 2 | $-12,661 |
| Christopher Grant Doughty | Chief Business Officer | Dec. 15, 2025 A | 62,194 | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | June 21, 2024 P | 680,403 | 0 | 0 | $0 |
| Bruce S Johnson | SVP & Chief Commercial Officer | Jan. 12, 2024 A | 138,980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | Jan. 12, 2024 A | · | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | Nov. 11, 2022 P | 29,161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | Nov. 11, 2022 P | 366,078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | Jan. 20, 2021 A | 183,115 | 0 | 0 | $0 |
| Alexandra Balcom | Director | June 2, 2026 A | · | 0 | 0 | $0 |
| Susan Moran | Director | June 2, 2026 A | · | 0 | 0 | $0 |
| Jonathan Violin | Director | June 2, 2026 A | · | 0 | 0 | $0 |
| David Charles Lubner | Director | June 2, 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Director | May 1, 2024 A | 515,194 | 0 | 0 | $0 |
| Scott Koenig | Director | May 1, 2024 A | 36,750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Director | May 1, 2024 A | 5,250 | 0 | 0 | $0 |
| Mark Alan Goldberg | Director | May 1, 2024 A | 24,828 | 0 | 0 | $0 |
| Timothy R Pearson | Director | May 1, 2024 A | 24,650 | 0 | 0 | $0 |
| Patricia S Andrews | Director | May 1, 2024 A | 58,608 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Director | May 1, 2024 A | 98,459 | 0 | 0 | $0 |
| James M Barrett | Director | May 18, 2018 A | 4,995,664 | 0 | 0 | $0 |
| John J. Baldwin | Director | June 29, 2016 M | 1,210 | 0 | 0 | $0 |
| Franklin H Top JR | Director | May 17, 2016 A | 12,294 | 0 | 0 | $0 |
| Michael A Henos | Director | July 15, 2015 A | 469,454 | 0 | 0 | $0 |
| William M. Gust | Director | Jan. 15, 2014 C | 409,947 | 0 | 0 | $0 |
| Scott D. Sandell | 10% owner | Jan. 26, 2023 S | 2,237,196 | 0 | 0 | $0 |
| Peter J Barris | 10% owner | May 10, 2018 X | 4,995,664 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 10 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.10% | 72,879 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.03% | 202,796 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 23,282 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 544,047 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 124,281 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 10,277 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 83,801 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 661,946 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,832 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 39,408 SH | Aug. 19, 2026 | Daily |
CBIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$28.00
+95.5%
6 40.0%
Strong Buy
7 46.7%
Buy
2 13.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-30Mean target $30.60 +113.7%
← Below all targets
Current price $14.32
Low$27.00
Mean$30.60
High$35.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| MNPR | · | · | · | · | · | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026